key: cord-0840240-tda2dcq7
authors: Greenhorn, Janet E.; Kotwa, Jonathon D.; Bowman, Jeff; Bruce, Laura; Buchanan, Tore; Buck, Peter A.; Dibernardo, Antonia; Flockhart, Logan; Gagnier, Marianne; Hou, Aaron; Jardine, Claire M.; Lair, Stephane; Lindsay, L. Robbin; Masse, Ariane; Muchaal, Pia K.; Nituch, Larissa A.; Sotto, Angelo; Stevens, Brian; Yip, Lily; Mubareka, Samira
title: SARS-CoV-2 wildlife surveillance in Ontario and Québec, Canada
date: 2021-12-03
journal: bioRxiv
DOI: 10.1101/2021.12.02.470924
sha: 563132603a2f01661a9b228df1420a5f62b4cc39
doc_id: 840240
cord_uid: tda2dcq7

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the COVID-19 pandemic, is capable of infecting a variety of wildlife species. Wildlife living in close contact with humans are at an increased risk of SARS-CoV-2 exposure and if infected have the potential to become a reservoir for the pathogen, making control and management more difficult. Objective To conduct SARS-CoV-2 surveillance in urban wildlife from Ontario and Québec, Canada, increasing our knowledge of the epidemiology of the virus and our chances of detecting spillover from humans into wildlife. Methods Using a One Health approach, we leveraged activities of existing research, surveillance, and rehabilitation programs among multiple agencies to collect samples from 776 animals from 17 different wildlife species between June 2020 and May 2021. Samples from all animals were tested for the presence of SARS-CoV-2 viral RNA, and a subset of samples from 219 animals across 3 species (raccoons, Procyon lotor; striped skunks, Mephitis mephitis; and mink, Neovison vison) were also tested for the presence of neutralizing antibodies. Results No evidence of SARS-CoV-2 viral RNA or neutralizing antibodies was detected in any of the tested samples. Conclusion Although we were unable to identify positive SARS-CoV-2 cases in wildlife, continued research and surveillance activities are critical to better understand the rapidly changing landscape of susceptible animal species. Collaboration between academic, public and animal health sectors should include experts from relevant fields to build coordinated surveillance and response capacity.

To conduct SARS-CoV-2 surveillance in urban wildlife from Ontario and Québec, Canada, 28 increasing our knowledge of the epidemiology of the virus and our chances of detecting 29 spillover from humans into wildlife. 30

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the global 48 COVID-19 pandemic and has been maintained through human-to-human transmission. 49

However, humans are not the only species susceptible to infection. Over the course of the 50 current pandemic, a range of domestic and wild animal species have been reported to either be 51 naturally infected with SARS-CoV-2 or susceptible to the virus in experimental infections (1, 2, 52

3). Others have been identified as potential hosts based on sequence analysis of the host cell 53 receptor of SARS-CoV-2, angiotensin 1 converting enzyme 2 (ACE2), and predicted binding 54 affinity (4, 5). 55

Many wild animal species thrive in the ecological overlap with humans and are thus at an 56 increased risk of being exposed to SARS-CoV-2 (6). Several of these peri-domestic species have 57 been experimentally shown to become infected with and shed SARS-CoV-2 (7, 8). SARS-CoV-2 58 infection has also been reported in wild or free-ranging animals that have been naturally 59 exposed, including American mink (Neovison vison; 9) and, more recently, white-tailed deer 60 (Odocoileus virginianus; 10, 11) . 61

The concept of One Health recognizes that human health and animal health are interdependent 62 (12). The spillover of virus from humans or domestic animals into wildlife is concerning not only 63 due to the possible deleterious effects on wildlife, but because these wild populations have the 64 potential to act as reservoirs for SARS-CoV-2. Diseases that have an animal reservoir are 65

inherently much more difficult to control and the spread of SARS-CoV-2 through animal 66 populations could further contribute to the development of variants of concern (VoCs), 67 potentially undermining the efficacy of medical countermeasures such as antivirals and 68 vaccines (13, 14). Additionally, people who have close contact with wildlife, such as biologists, 69 wildlife rehabilitators, and hunters and trappers, may be at higher risk of being exposed to the 70 virus and of facilitating its spread among wildlife. The impact of SARS-CoV-2 infection on 71 wildlife health is not fully understood. Early detection of any spillover is therefore critical to 72 preventing and addressing these concerns. 73

Given the risk of reverse-zoonotic SARS-CoV-2 transmission and our lack of knowledge of the 74 virus in local wildlife, there was an urgent need to elucidate the epidemiology of the virus at the 75 human-wildlife interface to help wildlife management and public health officials better 76 communicate risk and plan management strategies. We therefore conducted SARS-CoV-2 77 surveillance in wildlife across Ontario and Québec, Canada, with a major focus on the southern 78 regions of both provinces. These areas have high human population densities and include 79 major urban centres such as Toronto and Montréal. Incidences of COVID-19 peaked in 80

Montréal and the surrounding regions in early January 2021, with rates exceeding 400 cases per 81 100,000 population in Montréal and Laval (15). Incidences in Toronto and the surrounding 82 regions peaked in April 2021, with case rates in the City of Toronto and Peel also exceeding 400 83 per 100,000 population (15). 84

Many experts have recommended a One Health approach for animal SARS-CoV-2 testing, which 86 balances concerns for both human and animal health and is based on knowledge of experts in 87 both fields (16, 17). As such, our work was conducted through consultation and cooperation 88 Institute (SRI). We focussed our surveillance primarily on animals from urban areas or those 95 with a case history of close contact with people since these animals would be at the highest risk 96 of exposure to people infected with SARS-CoV-2. All samples for testing were collected 97 between June 2020 and May 2021 through pre-existing partnerships or over the course of 98 other research, surveillance, or rehabilitation work (Table 1) . 99

Raccoons (Procyon lotor) and striped skunks (Mephitis mephitis) are peri-domestic species that 101 are good candidates for reverse-zoonotic disease surveillance due to their high density in urban 102 areas and their frequent close contact with people, pets, and refuse. They are also subject to 103 ongoing rabies surveillance operations in both Ontario and Québec, making them easy to 104 sample. In Ontario, wildlife rabies surveillance and testing are conducted by the NDMNRF on 105 roadkill, animals found dead for other reasons, and deceased sick or strangely acting wildlife. 106

Submissions are received mainly from southwestern Ontario, and most animals received by the 107

program and subsequently sampled and tested for SARS-CoV-2 came from urban centres within 108 this region (Figure 1 ). In Québec, a similar wildlife rabies surveillance program is coordinated 109 by the MFFP and testing and other post-mortem examinations are performed by the Québec 110 CWHC. As was the case in Ontario, animals sampled by the Québec CWHC for SARS-CoV-2 111 testing came mainly from urban areas (Figure 1 ). The Ontario CWHC laboratory also 112 contributed a small number of raccoon and skunk samples from animals submitted to them for 113 post-mortem examination. Carcasses were sampled using a combination of oral, nasal, and 114 rectal swabs, respiratory tissue, and intestinal tissue (Table 1) Aleutian Mink Disease), which can spread to wild mink populations (23). 132

The majority of mink carcasses we sampled for SARS-CoV-2 were submitted to the NDMNRF by 133 licensed fur harvesters through a collaboration with the Ontario Fur Managers Federation. The 134 NDMNRF staff collected oral and rectal swabs, lung tissue, and intestinal tissue from the 135 carcasses, as well as cardiac blood samples via cardiac puncture for antibody testing. If blood 136 could not be obtained from the heart, fluid was collected from the chest cavity on a Nobuto 137 filter strip (Advantec MFS, Inc, Dublin, CA, USA). Nobuto strips were allowed to air dry, then 138 placed in individual coin envelopes. 139

Bats are known carriers of coronaviruses (24, 25, 26). As such, concerns have been raised over 141 the possible susceptibility of North American bats to SARS-CoV-2 (27). Species such as the big 142 brown bat (Eptesicus fuscus) frequently roost in buildings, which brings them into close contact 143 with people and increases the likelihood of SARS-CoV-2 exposure. Big brown bat oral swabs 144 and guano samples for SARS-CoV-2 PCR testing were collected by staff at the Granby Zoo, which 145 runs a rehabilitation program over the winter to care for bats that have been disturbed during 146 their hibernation. Guano samples were stored dry in 2 mL tubes. 147

Other samples for SARS-CoV-2 PCR testing were obtained opportunistically through the Ontario 149 and Québec regional CWHC laboratories, which receive a wide variety of wildlife species for 150 post-mortem examination (Table 1) . Animals were selected for sampling based on potential for 151 SARS-CoV-2 infection. This could be due to urban habitat, human contact, or to predicted 152 species susceptibility based on prior research. The number and type of samples collected 153 varied by carcass and depended on carcass condition (Table 1) . 154

RNA extraction and PCR testing were performed at the SRI in Toronto, Ontario. All swab, tissue, 

Our study did not detect any spillover of SARS-CoV-2 to wildlife in Ontario and Québec. 207

Raccoons and skunks were the most commonly tested species. Results from experimental 208 studies have suggested these species may be susceptible to SARS-CoV-2, but the lack of and low 209 quantity of infectious virus from raccoons and skunks, respectively, suggest they are an unlikely 210 reservoir for SARS-CoV-2 in the absence of viral adaptations (7, 8) . Similarly, a recent challenge 211 study with big brown bats found that they are resistant to SARS-CoV-2 infection and do not 212 shed infectious virus (28). Conversely, mink are susceptible to SARS-CoV-2 infection, but we did 213 not detect evidence of SARS-CoV-2 in any of the mink sampled. While this could be attributed 214 to our low effective sample size, to date SARS-CoV-2 has been infrequently detected in wild 215 mink populations globally. It should be noted, however, that the abovementioned experimental 216 studies on raccoons, skunks, and big brown bats were conducted using parental SARS-CoV-2. 217

The susceptibility of these species to VoCs is presently not known and may differ from 218 susceptibility to the parental strain (29). Additionally, challenge studies assessing susceptibility 219 tend to be conducted on small numbers of young, healthy individuals, so results may not be 220 reflective of the full range of possible responses to infection in the wild. 221

As the pandemic progresses, new evidence is emerging on susceptible wildlife that may act as 222 competent reservoirs for the virus. For example, white-tailed deer are now considered a highly 223 relevant species for SARS-CoV-2 surveillance in light of their experimentally determined 224 susceptibility as well as evidence of widespread exposure to the virus via antibody and PCR 225 testing across the northeastern USA (10, 11, 30) . Continued surveillance efforts should be 226 adaptive and include targeted testing of highly relevant species as they are identified. In 227

Ontario and Québec, these would include mink, white-tailed deer, and deer mice (Peromyscus 228 maniculatus; 7, 31). Continuing to include less susceptible species remains important given 229 ongoing viral genomic plasticity and changing host range of VoCs. 230

There are several limitations for this study that need to be acknowledged. First, the majority of 232 our SARS-CoV-2 testing was done by RT-PCR, which is only capable of detecting active infection. 233

Antibody testing, which identifies resolved infection or exposure, is more likely to find evidence 234 of SARS-CoV-2 in surveillance studies since results are less dependent on timing of sample 235 collection. Antibody testing typically requires samples from live animals or fresh carcasses, 236 which limited our ability to use it. However, the testing performed allowed for test validation in 237 raccoons, skunks, and mink which may facilitate more antibody testing in future. Second, the 238 type of samples we collected may also have limited our ability to detect SARS-CoV-2 infection. 239

Viral replication can vary among tissue types and therefore some tissues are more optimal for 240 viral RNA detection than others (1). In the present work, animals were sampled 241 opportunistically as a part of pre-existing surveillance efforts, research, and rehabilitation 242 programs and we were not able to consistently collect the same sample sets from all animals. 243

Additionally, the sample types were from live animals and carcasses and not optimized; certain 244 sample types were sometimes unavailable (e.g. tissue samples from live animals) or were not 245 sufficient for collection. 246 The authors wish to thank B. Pickering and J. Tataryn for facilitating the inter-agency 272 partnerships that made this work possible, and for their thoughtful review and comments on 273 the manuscript. We also wish to acknowledge B. Pickering for helping to arrange antibody 274 testing, and N. P. L. Toledo for performing the antibody testing. We are grateful for the work of 275 D. Bulir in developing the PCR testing assay used in this study. We wish to thank L. Lazure and 276 the staff of the Granby Zoo, the technicians of the Québec rabies surveillance program, and V. 

SARS-CoV-2 324 exposure in wild white-tailed deer (Odocoileus virginianus). bioRxiv 2021

SARS-CoV-2 infection in free-ranging 329 white-tailed deer (Odocoileus virginianus). bioRxiv 2021

World Organization for Animal Health (OIE). One Health

Preliminary report of an 337 outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread

SARS-CoV-2 341 evolution in animals suggestions mechanisms for rapid variant selection

Considerations for sampling, testing, and 347 reporting of SARS-CoV-2 in animals

Assessing the risks of SARS-CoV-2 in 352 wildlife

SARS-CoV-2 infection in farmed minks

PRO/AH/EDR> COVID-19 update (531): animal, Canada (BC) mink

SARS-CoV-2 transmission between mink 364 (Neovison vison) and humans

370 Transmission of SARS-CoV-2 on mink farms between humans and mink and back to 371 humans

SARS-CoV-2 infection in 376 cats and dogs in infected mink farms

Mink farms predict Aleutian 379 disease exposure in wild American mink

Detection of group 1 coronaviruses in 382 bats in North America

Detection of polyoma and corona viruses in bats of Canada

389 Isolation and characterization of a bat SARS-like coronavirus that uses the ACE-2 390 receptor

Wang 395 LF. Possibility for reverse-zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: a 396 case study of bats

Experimental challenge of a North American bat species, big 400 brown bat (Eptesicus fuscus), with SARS-CoV-2

The B1.351 and P.1 variants extend SARS-CoV-2 host range to mice. 405 bioRxiv 2021

Susceptibility 408 of white-tailed deer (Odocoileus virginianus) to SARS-CoV-2

SARS-CoV-2 infection and transmission in the 414 North American deer mouse